Advertisement
Singapore markets close in 2 hours 12 minutes

  • Straits Times Index

    3,171.91
    -15.75 (-0.49%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,190.87
    -195.00 (-1.19%)
     

  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     

  • Bitcoin USD

    63,792.09
    +2,786.48 (+4.57%)
     

  • CMC Crypto 200

    1,284.13
    -28.49 (-2.18%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,396.00
    -2.00 (-0.08%)
     

  • Crude Oil

    83.87
    +1.14 (+1.38%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • FTSE Bursa Malaysia

    1,550.06
    +5.30 (+0.34%)
     

  • Jakarta Composite Index

    7,063.10
    -103.72 (-1.45%)
     

  • PSE Index

    6,424.68
    -98.51 (-1.51%)
     

Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg

Reuters

(Reuters) - Pfizer Inc (PFE.N) is exploring sale of a group of treatments in cardiology, urology and primary care, Bloomberg reported on Thursday, citing people familiar with the matter.

The drugs could fetch more than $2 billion (£1.6 billion), Bloomberg reported.

Pfizer is working with financial adviser JPMorgan Chase & Co for the potential portfolio sale and the process is at a preliminary stage, Bloomberg said.

Pfizer could not be immediately reached for comment.

(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by Savio D'Souza)